BioStock: Invent Medic remains active in femtech consolidation going forward – CEO

24 August 2023 - 09:45

After a strong first quarter, Invent Medic follows the trend and reports sales of more than 2 MSEK for the second quarter of 2023. CEO Anna Lindström tells BioStock about the positive sales trend and how she views the opportunities for further acquisitions in the women’s health sector.

Read the full article at

This is a press release from BioStock - Connecting Innovation & Capital.

Provided by: Cision
Spotlight Stock Market (Sweden)
Invent Medic Sweden AB
Invent Medic focus on female health, where the company currently develops products for incontinence. The product is named TVS, and the vision is to improve quality of life for women with female-related health problems....
Learn more about company

Related news

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More